Hemogenyx Pharmaceuticals Plc (LON:HEMO)
London · Delayed Price · Currency is GBP · Price in GBX 930.00
+24.00 (2.65%)
At close: Feb 12, 2026
Hemogenyx Pharmaceuticals Market Cap
Hemogenyx Pharmaceuticals has a market cap or net worth of 57.75 million as of February 12, 2026. Its market cap has increased by 339.58% in one year.
Market Cap
57.75M
Enterprise Value
59.68M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
930.00
Market Cap Chart
Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has increased from 10.68M to 57.75M, an increase of 440.70%. That is a compound annual growth rate of 22.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 59.28M | 71.56% |
| Dec 31, 2025 | 34.56M | 143.47% |
| Dec 31, 2024 | 14.19M | -47.51% |
| Dec 29, 2023 | 27.04M | 108.28% |
| Dec 30, 2022 | 12.98M | -29.33% |
| Dec 31, 2021 | 18.37M | -56.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 128.68M |
| Bioventix | 92.74M |
| 4basebio | 91.32M |
| Faron Pharmaceuticals Oy | 66.58M |
| SkinBioTherapeutics | 51.13M |
| hVIVO | 48.31M |
| Ondine Biomedical | 41.09M |
| Poolbeg Pharma | 32.43M |